

Author: Garattini Livio > Curto Alessandro
Publisher: Adis International
ISSN: 1172-0360
Source: Drugs & Therapy Perspectives, Vol.28, Iss.11, 2012-11, pp. : 23-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
In Italy, the government has recently approved reforms to promote competition by `liberalizing' traditionally highly regulated markets, including pharmacies. The Italian strategy for liberalizing the pharmacy sector is evaluated and compared with current regulations in five main western EU countries. Based on this comparison, the reforms in Italy may not benefit patients or the Italian National Health Service.
Related content










National Health Service Litigation Authority: 10 years on
By Mead John
Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. :